Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Principal Scientist, Biosimilars Process Development at Amgen Inc.
Renuka Sivendran is a Similarity Leader for three biosimilar programs at Amgen. She was a Drug Product Team Leader in the Drug Product Process Development Group at Amgen prior to joining the Biosimilars Business Unit in December 2014. She moved to Amgen in January 2012 from Regeneron Pharmaceuticals in Tarrytown, NY, where she was a Scientist in the Formulation Development Group in Pre-Clinical Development. Dr. Sivendran obtained her bachelor’s degree in chemistry from Millersville University of Pennsylvania and worked as an intern at DuPont Chemicals in Deepwater, NJ. She received her Ph.D. in biophysics from the University of Massachusetts in Amherst and studied how heat shock proteins prevent protein misfolding and aggregation under stress conditions. She did her postdoctoral fellowship at the National Cancer Institute at the National Institutes of Health in Bethesda, MD and studied the role of Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) in anti-angiogenesis.